Oncogenes in prostate cancer. An update
โ Scribed by Donna M. Peehl
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 634 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
c-erb BYneu has been demonstrated to be a transforming oncogene in both rodent and human prostatic epithelial cells. To understand the potential role of neu in human prostatic cancer progression, we used a gene transfer procedure to determine whether neu amplificatiodoverexpression leads to increase
## Abstract In 1920, Warburg suggested that tumors consistently rely on anaerobic pathways to convert glucose to ATP even in the presence of abundant oxygen [Warberg, 1956] despite the fact that it is less efficient for energy supply than aerobic glycolysis. The reasons for this remain obscure to d
## BACKGROUND. Neuroendocrine differentiation in prostatic carcinoma may be related to the growth and prognosis of prostate cancer, especially androgen-insensitive tumors. MATERIALS AND METHODS. This update reviews new investigations relating to neuroendocrine differentiation of prostatic carcinom
## Background: A consensus meeting on screening and global strategy for prostate carcinoma, held in antwerp in 1994, determined the willingness among european cancer prevention centers to pursue vigorously the collaborative formation of a multinational randomized screening trial. this trial was to